Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT10109 Dose-finding for Glabellar Lines
NCT01485601Phase 2Completed
- Sponsor
- Medytox Inc.
- Start
- Dec 2011
- Primary completion
- Mar 2012
- Modality
- Bacterial Toxin Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of nivobotulinumtoxinA in glabellar lines, sponsored by Medytox Inc.. Started Dec 2011; status: completed.
02
Drugs
nivobotulinumtoxinA
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT01485601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01485601.